Caverject - 0009-5131-02 - (ALPROSTADIL)

Alphabetical Index


Drug Information of Caverject

Product NDC: 0009-5131
Proprietary Name: Caverject
Non Proprietary Name: ALPROSTADIL
Active Ingredient(s): 5.4    ug/mL & nbsp;   ALPROSTADIL
Administration Route(s): INTRACAVERNOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Caverject

Product NDC: 0009-5131
Labeler Name: Pharmacia and Upjohn Company
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020379
Marketing Category: NDA
Start Marketing Date: 19950706

Package Information of Caverject

Package NDC: 0009-5131-02
Package Description: 6 VIAL, SINGLE-DOSE in 1 PACKAGE (0009-5131-02) > 1 mL in 1 VIAL, SINGLE-DOSE

NDC Information of Caverject

NDC Code 0009-5131-02
Proprietary Name Caverject
Package Description 6 VIAL, SINGLE-DOSE in 1 PACKAGE (0009-5131-02) > 1 mL in 1 VIAL, SINGLE-DOSE
Product NDC 0009-5131
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ALPROSTADIL
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRACAVERNOUS
Start Marketing Date 19950706
Marketing Category Name NDA
Labeler Name Pharmacia and Upjohn Company
Substance Name ALPROSTADIL
Strength Number 5.4
Strength Unit ug/mL
Pharmaceutical Classes Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE]

Complete Information of Caverject


General Information